Candriam SCA’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.5M | Sell |
27,214
-19,935
| -42% | -$5.63M | 0.03% | 321 |
|
|
2026
Q1 | $12.6M | Sell |
47,149
-33,035
| -41% | -$9.14M | 0.07% | 243 |
|
|
2025
Q4 | $22.1M | Buy |
80,184
+3,021
| +4% | +$847K | 0.11% | 180 |
|
|
2025
Q3 | $22.2M | Buy |
77,163
+2,214
| +3% | +$655K | 0.12% | 168 |
|
|
2025
Q2 | $24.8M | Sell |
74,949
-98,682
| -57% | -$31.8M | 0.14% | 138 |
|
|
2025
Q1 | $57.1M | Buy |
173,631
+96,750
| +126% | +$29.1M | 0.36% | 70 |
|
|
2024
Q4 | $21.2M | Buy |
76,881
+52,119
| +210% | +$16.6M | 0.12% | 157 |
|
|
2024
Q3 | $8.58M | Sell |
24,762
-45,949
| -65% | -$15.8M | 0.05% | 285 |
|
|
2024
Q2 | $23.4M | Buy |
70,711
+42,453
| +150% | +$14.6M | 0.14% | 148 |
|
|
2024
Q1 | $10.3M | Buy |
28,258
+7,826
| +38% | +$2.58M | 0.07% | 253 |
|
|
2023
Q4 | $6.12M | Sell |
20,432
-2,018
| -9% | -$590K | 0.04% | 312 |
|
|
2023
Q3 | $6.42M | Sell |
22,450
-728
| -3% | -$208K | 0.05% | 286 |
|
|
2023
Q2 | $6.5M | Sell |
23,178
-20,387
| -47% | -$5.31M | 0.05% | 298 |
|
|
2023
Q1 | $10.2M | Sell |
43,565
-6,747
| -13% | -$1.97M | 0.07% | 256 |
|
|
2022
Q4 | $16.7M | Sell |
50,312
-8,005
| -14% | -$2.53M | 0.11% | 191 |
|
|
2022
Q3 | $16.2M | Buy |
58,317
+26,833
| +85% | +$7.55M | 0.11% | 193 |
|
|
2022
Q2 | $8.3M | Sell |
31,484
-23,088
| -42% | -$5.95M | 0.07% | 252 |
|
|
2022
Q1 | $13.1M | Sell |
54,572
-2,269
| -4% | -$531K | 0.09% | 217 |
|
|
2021
Q4 | $13.1M | Buy |
56,841
+20,721
| +57% | +$4.4M | 0.08% | 226 |
|
|
2021
Q3 | $7.23M | Sell |
36,120
-1,674
| -4% | -$364K | 0.05% | 327 |
|
|
2021
Q2 | $8.96M | Sell |
37,794
-57,279
| -60% | -$14.3M | 0.06% | 304 |
|
|
2021
Q1 | $19M | Hold |
95,073
| – | – | 0.16% | 148 |
|
|
2020
Q4 | $19.8M | Sell |
95,073
-2,078
| -2% | -$408K | 0.16% | 149 |
|
|
2020
Q3 | $16.5M | Buy |
97,151
+32,202
| +50% | +$5.67M | 0.15% | 158 |
|
|
2020
Q2 | $12.2M | Sell |
64,949
-7,110
| -10% | -$1.35M | 0.13% | 187 |
|
|
2020
Q1 | $14.4M | Buy |
72,059
+4
| +0% | +$776 | 0.16% | 149 |
|
|
2019
Q4 | $14.7M | Buy |
72,055
+2,168
| +3% | +$397K | 0.16% | 149 |
|
|
2019
Q3 | $10.6M | Sell |
69,887
-2,185
| -3% | -$356K | 0.14% | 172 |
|
|
2019
Q2 | $11.3M | Sell |
72,072
-20,945
| -23% | -$3.28M | 0.14% | 169 |
|
|
2019
Q1 | $15M | Sell |
93,017
-26,704
| -22% | -$4.88M | 0.19% | 117 |
|
|
2018
Q4 | $22.7M | Sell |
119,721
-44,678
| -27% | -$9.32M | 0.35% | 53 |
|
|
2018
Q3 | $34.2M | Buy |
164,399
+157
| +0.1% | +$29.1K | 0.46% | 43 |
|
|
2018
Q2 | $27.9M | Sell |
164,242
-32,220
| -16% | -$5.58M | 0.44% | 43 |
|
|
2018
Q1 | $33M | Buy |
196,462
+52,589
| +37% | +$10.2M | 0.56% | 30 |
|
|
2017
Q4 | $29.2M | Buy |
143,873
+83,228
| +137% | +$16.6M | 0.51% | 45 |
|
|
2017
Q3 | $11.3M | Buy |
60,645
+42,987
| +243% | +$7.65M | 0.2% | 138 |
|
|
2017
Q2 | $2.96M | Buy |
17,658
+1,819
| +11% | +$292K | 0.06% | 386 |
|
|
2017
Q1 | $2.32M | Buy |
15,839
+2,672
| +20% | +$394K | 0.04% | 414 |
|
|
2016
Q4 | $1.76M | Buy |
13,167
+376
| +3% | +$49.2K | 0.04% | 393 |
|
|
2016
Q3 | $1.67M | Sell |
12,791
-75,622
| -86% | -$9.87M | 0.04% | 393 |
|
|
2016
Q2 | $11.3M | Buy |
88,413
+75,419
| +580% | +$9.96M | 0.29% | 91 |
|
|
2016
Q1 | $1.77M | Sell |
12,994
-21,114
| -62% | -$2.9M | 0.04% | 340 |
|
|
2015
Q4 | $4.99M | Buy |
34,108
+26,066
| +324% | +$3.58M | 0.13% | 178 |
|
|
2015
Q3 | $1.09M | Sell |
8,042
-61,586
| -88% | -$8.94M | 0.03% | 425 |
|
|
2015
Q2 | $11.3M | Sell |
69,628
-104,909
| -60% | -$14.5M | 0.23% | 123 |
|
|
2015
Q1 | $22.6M | Sell |
174,537
-183,198
| -51% | -$21.3M | 0.46% | 53 |
|
|
2014
Q4 | $36.8M | Buy |
+357,735
| New | +$35.3M | 0.77% | 21 |
|
Other funds holding CI
Candriam SCA's CI Position: Q2 2026 in Review
Candriam SCA reduced its Cigna (CI) stake by 42% in Q2 2026, selling an estimated $5.63M and leaving 27,214 shares worth $7.5M. The position accounts for 0.03% of the portfolio, ranked #321.
Candriam SCA first reported a position in CI in Q4 2014 and has held it in 47 quarters since. The position peaked at $57.1M in Q1 2025. 1,692 funds tracked by Wall St. Rank hold CI as of Q2 2026.
- Candriam SCA held 27,214 shares of Cigna worth $7.5M as of Q2 2026.
- Candriam SCA sold 19,935 Cigna shares in Q2 2026, an estimated $5.63M.
- Cigna made up 0.03% of Candriam SCA's portfolio in Q2 2026, its #321 holding.
- Candriam SCA first reported a position in Cigna in Q4 2014 and has held it in 47 quarters since.
- Candriam SCA's Cigna position peaked at $57.1M in Q1 2025.
- 1,692 funds tracked by Wall St. Rank held Cigna as of Q2 2026.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.